Wockhardt Usa Recalls
45 recalls on record · February 5, 2014 to November 1, 2017 · Drugs
Recalls by year
14
15
17
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
November 1, 2017DrugsFDA
Wockhardt Usa Inc. recalls Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Ar
Hazard: Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.
August 26, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 20 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distribut
Hazard: CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
August 26, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distribute
Hazard: CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Captopril Tablets, USP, 100 mg Tablets, Packaged in 100 Count Bottles, Rx only. Manufactured by: Wockhardt Limited, Mumb
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Captopril Tablets, USP, 50 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0904-01) and B) 1000 Count Bottles (
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Captopril Tablets, USP, 25 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0903-01) and B) 1000 Count Bottles (
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Zonisamide Capsules, 25 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Zonisamide Capsules, 50 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 25 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0734-02)
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 50 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0735-02)
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 100 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0736-02
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lansoprazole Delayed-Release Capsules, USP, 30 mg Capsules, Packaged in A) 30 Count Bottles (NDC: 64679-0670-01), B) 90
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules, Packaged in 30 Count Bottles, Rx only. Manufactured by: Wock
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Famotodine Tablets, USP, 10 mg Tablets, For Repacking Only, Packaged in 50,000 Count Drums, Over the Counter. Manufactu
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 Count Drums, Over the Counter. Manufacture
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Famotodine Tablets, USP, 20 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-936-01), B) 100 Count Bottles(NDC:
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Azithromycin Tablets, USP, 600 mg Tablets, Packaged in 30 Count Bottles, Rx only. Manufactured by: Wockhardt Limited, Mu
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Azithromycin Tablets, USP, 500 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-0964-01) and B) 3 x 3 Tablet Card
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Zolpidem Tartrate Tablets, 10 mg Tablets, CIV, Packaged in A) 100 Count Bottles (NDC: 64679-715-01) and B) 500 Count Bo
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 40 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-942-01), B) 500 Count Bottles (NDC:
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-953-01) and B) 500 Count Bottles (
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 20 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-941-01), B) 500 Count Bottles (NDC:
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 10 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-929-01), B) 500 Count Bottles (NDC:
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 5 mg Tablets,Packaged in A) 100 Count Bottles (NDC: 64679-928-01), B) 500 Count Bottles (NDC: 64
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Amlodipine Besylate Tablets, 10 mg Tablets, Packaged as A) 90 Count Bottles (NDC: 64679-423-01) and B) 1000 Count Bott
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Amlodipine Besylate Tablets, 5 mg Tablets, Packaged as A) 90 Count Bottles (NDC: 64679-422-01) and B) 1000 Count Bottles
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Zonisamide Capsules, 100 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumba
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Tamsulosin Hydrochloride Capsules, USP*, 0.4 mg Capsules, Packaged in A) 100 Count Bottles (NDC: 64679-516-02) and B) 50
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 200 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0737-02
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.
July 29, 2015DrugsFDA
Wockhardt Usa Inc. recalls Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules, For Repackaging Only, Packaged in 4500 Count Pouches, Over t
Hazard: CGMP Deviations: Firm did not adequately investigate customer complaints.